Literature DB >> 6157763

Expression of HLA-A, -B, and -C and beta 2-microglobulin antigens in human choriocarcinoma cell lines.

J Trowsdale, P Travers, W F Bodmer, R A Patillo.   

Abstract

Immunoprecipitation of [35S]methionine-labeled cell extracts and analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis showed that cells from two human choriocarcinomas JaR and BeWo contained beta 2-microglobulin. The JaR cells, and one subline of BeWo, did not express surface HLA-A, -B, and -C (HLA-ABC) antigens, nor did JaR contain the antigens when cell-free extracts were measured in a sensitive radioimmunoassay. It may be concluded that the lack of expression of HLA-ABC antigens in choriocarcinoma (and in the trophoblast) is not a result of lack of beta 2-microglobulin, as is the case for the Burkitt's lymphoma cell line, Daudi.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6157763

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  Inhibition of HLA class I antigen and mRNA expression induced by Rous sarcoma virus in transformed human fibroblasts.

Authors:  J Gogusev; B Teutsch; M T Morin; F Mongiat; F Haguenau; G Suskind; G F Rabotti
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

2.  HLA-E is the only class I gene that escapes CpG methylation and is transcriptionally active in the trophoblast-derived human cell line JAR.

Authors:  J Boucraut; T Guillaudeux; M Alizadeh; J Boretto; G Chimini; F Malecaze; G Semana; R Fauchet; P Pontarotti; P Le Bouteiller
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

3.  A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma.

Authors:  P G Coulie; F Lehmann; B Lethé; J Herman; C Lurquin; M Andrawiss; T Boon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

4.  Correlation between classification of human urothelial cell lines and HLA-A,B,C expression.

Authors:  S S Ottesen; V Tromholt; J Kieler
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

Review 5.  Immunobiology of complete molar pregnancy and gestational trophoblastic tumor.

Authors:  R S Berkowitz; S A Umpierre; S Taylor-Emery; D P Goldstein; D J Anderson
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

6.  Tumour-induced polarization of tumour vaccine-draining lymph node T cells to a type 1 cytokine profile predicts inherent strong immunogenicity of the tumour and correlates with therapeutic efficacy in adoptive transfer studies.

Authors:  Hauke Winter; Hong-Ming Hu; Christian H Poehlein; Erik Huntzicker; John J Osterholzer; Jaffar Bashy; David Lashley; Bruce Lowe; Jane Yamada; Gregory Alvord; Walter J Urba; Bernard A Fox
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

7.  Introduction of a human X-6 translocation chromosome into a mouse teratocarcinoma: investigation of control of HLA-A, B, C expression.

Authors:  P N Goodfellow; G Banting; J Trowsdale; S Chambers; E Solomon
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

8.  Control of synthesis and expression of H-2 heavy chain and beta-2 microglobulin in AKR leukemias.

Authors:  W Schmidt; U Henseling; D Bevec; A D Alonzo; H Festenstein
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

9.  Phenotypic expression of histocompatibility antigens in human primary tumours and metastases.

Authors:  F Ruiz-Cabello; M A Lopez Nevot; J Gutierrez; M R Oliva; C Romero; A Ferron; F Esteban; C Huelin; M A Piris; C Rivas
Journal:  Clin Exp Metastasis       Date:  1989 Mar-Apr       Impact factor: 5.150

10.  Serum beta 2-microglobulin in chronic diseases of the pancreas.

Authors:  R Pezzilli; P Billi; M Fiocchi; E Beltrandi; O Cappelletti; G Sprovieri; M Miglioli
Journal:  Int J Pancreatol       Date:  1995-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.